Brought to you by 
Mirum goes public via $69.75mm IPO
Jul 2019
Executive Summary
Mirum Pharmaceuticals Inc. (liver disease therapies) netted $69.75mm through its initial public offering of 5mm common shares at $15, the midpoint of its $14-16 intended range.
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com